Skip to main content
Contact Us
Subscribe
E-Edition
91°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Becton Dickinson
(NY:
BDX
)
242.41
+1.44 (+0.60%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Becton Dickinson
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
March 26, 2023
These three spinoffs are already profitable.
Via
The Motley Fool
3 Stocks To Buy For Consistent Dividend Growth
March 11, 2023
One way to avoid some of the volatility in the stock market is to buy old companies that have a long history of raising dividends. These are companies with iconic brands, lasting products, and...
Via
Talk Markets
Becton, Dickinson's Debt Overview
March 10, 2023
Via
Benzinga
(BDX) - Analyzing Becton, Dickinson's Short Interest
March 09, 2023
Via
Benzinga
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Via
News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
March 01, 2023
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices.
Via
Benzinga
Looking Into Becton's Return On Capital Employed
February 03, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Becton, Dickinson
February 03, 2023
Via
Benzinga
A Bullish Sign Appears On Becton, Dickinson's Chart
January 24, 2023
Via
Benzinga
The 7 Best Dividend Growth Stocks for Long-Term Investors
February 22, 2023
Although passive income is always useful under uncertain times, why not get capital gains through the best dividend growth stocks?
Via
InvestorPlace
Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
February 17, 2023
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.
Via
Benzinga
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
February 15, 2023
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in...
Via
Benzinga
Why Embecta Stock Popped by Nearly 13% Today
February 14, 2023
Twin beats and raised guidance make for a good day on the market for the diabetes care specialist.
Via
The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Via
News Direct
Topics
Economy
Exposures
Supply Chain
What 6 Analyst Ratings Have To Say About Becton, Dickinson
January 06, 2023
Via
Benzinga
2 Medical Stocks to Watch Heading Into 2023
December 31, 2022
The two healthcare companies easily outdid the S&P 500 this year.
Via
The Motley Fool
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
January 17, 2023
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the...
Via
Benzinga
Becton Dickinson, Freeport-McMoRan, GXO Logistics And This Mid-Cap ETF On CNBC's 'Final Trades'
January 10, 2023
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named iShares Core S&P Mid-Cap ETF (NYSE: IJH), saying that "mid-c
Via
Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
January 09, 2023
Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development...
Via
Benzinga
2 Relatively Safe Dividend Stocks to Buy Today and Hold Forever
January 02, 2023
They already have extensive track records of success, and there's even more on the way.
Via
The Motley Fool
Embecta Stock Tumbles On Mixed Q4 Results, Softer Guidance
December 20, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About Becton, Dickinson
December 12, 2022
Via
Benzinga
2 Top Dividend Kings to Buy for the Long Haul
December 14, 2022
No matter how much changes, these two healthcare giants keep performing.
Via
The Motley Fool
Reliable Passive Income: an Analysis on Dividend Kings
December 13, 2022
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via
Benzinga
NIO To $34? Plus This Analyst Sees $245 For Becton, Dickinson and Company
November 11, 2022
Piper Sandler cut the price target on Becton, Dickinson and Company (NYSE: BDX) from $255 to $245. Piper Sandler analyst Jason Bednar maintained the stock with a Neutral. Becton, Dickinson shares...
Via
Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,700 Today
November 10, 2022
Becton, Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 3.41% on an annualized basis producing an average annual return of 11.05%. Currently, Becton, Dickinson has a market...
Via
Benzinga
Becton Dickinson's FY23 Guidance Trails Wall Street View Reflecting Foreign Currency Impact
November 10, 2022
Via
Benzinga
Got $5,000? Buy These 3 Dividend Kings And Hold Them Forever
November 02, 2022
These healthcare companies should stay relevant for years as they continue to innovate with new products.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.